Mercia Asset Management
Status
ACTIVE
Global HQ
United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
Industries
- Health Tech
- Media
- Entertainment
- PropTech
- Biotechnology
- Mobility
About
Mercia Asset Management is a dynamic and specialized asset management firm dedicated to empowering UK businesses with high growth potential. With a robust portfolio of investment solutions, including venture capital, private equity, and tailored business loans ranging from £100,000 to £10 million, Mercia is committed to fostering innovation and driving sustainable growth. Their expert team works closely with entrepreneurs to identify opportunities and navigate challenges, ensuring that each investment aligns with the strategic vision of the business. By leveraging deep market insights and a collaborative approach, Mercia Asset Management positions itself as a trusted partner for companies looking to scale and achieve their ambitious goals.
Mercia Asset Management is a dynamic and specialized asset management firm dedicated to empowering UK businesses with high growth potential. With a robust portfolio of investment solutions, including venture capital, private equity, and tailored business loans ranging from £100,000 to £10 million, Mercia is committed to fostering innovation and driving sustainable growth. Their expert team works closely with entrepreneurs to identify opportunities and navigate challenges, ensuring that each investment aligns with the strategic vision of the business. By leveraging deep market insights and a collaborative approach, Mercia Asset Management positions itself as a trusted partner for companies looking to scale and achieve their ambitious goals.
Investment Thesis
Fuelling UK business ambitions and forging longterm partnerships, Mercia provides venture capital, private equity, and debt investment ranging from £100k to £10m to accelerate growth and impact.
Manager's Experience
With extensive experience in private equity, the fund manager has actively invested in technology and healthcare sectors across Europe and North America. Having successfully completed over 20 deals, they focus on growth-stage investments, emphasizing a data-driven approach to identify market opportunities. Their strategic style prioritizes operational improvements, which has led to notable exits in the software and biotechnology spaces, showcasing their ability to deliver strong returns. This diverse portfolio reflects a commitment to thematic investing aligned with emerging market trends.
Team
Stephen Windsor
Peter Dines
Paul Mattick
Paul Taberner
Katy Horrocks
Jen Lau
Ashish Patel